{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"99.7","value":"142.9"},{"groupId":"OG001","spread":"91.0","value":"118.9"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"42"},{"groupId":"OG001","value":"42"}],"units":"Participants"}],"description":"Radiopharmaceutical dosimetry was assessed based on the numerical tumor-absorbed dose value in Gray as calculated by SurePlan (MIM Software Inc, Cleveland, Ohio). The outcome is reported as the median tumor-absorbed dose in Gray for each scan method (90Y PET/CT and 99mTc-MAA SPECT/CT), with standard deviation.","dispersionType":"Standard Error","groups":[{"description":"All participants receive Y-90 PET/CT Scan\n\nComputed Tomography (CT): As part of PET/CT scan. Positron Emission Tomography (PET): As part of PET/CT scan\n\n90-Yttrium (Y-90) Glass Microspheres: Radiolabel for PET/CT scan","id":"OG000","title":"Yttrium Y-90 PET/CT"},{"description":"All participants receive 99mTc-MAA SPECT/CT scan\n\nComputed Tomography (CT): As part of SPECT/CT scans. Single-photon emission computerized tomography (SPECT) scan: As part of SPECT/CT scan\n\nTechnetium 99mTc albumin aggregated (99mTc-MAA): Radiolabel for 99mTc-MAA SPECT/CT Scan","id":"OG001","title":"99mTc-MAA SPECT/CT Scans"}],"paramType":"MEDIAN","reportingStatus":"POSTED","timeFrame":"1 day","title":"Radiopharmaceutical Dosimetry Accuracy for 90-Y PET/CT Scans and 99mTc-MAA SPECT/CT Scans","type":"SECONDARY","unitOfMeasure":"Gray"}